| Feb. 27, 2017 |
H.R.1231 |
To amend the Federal Food, Drug, and Cosmetic Act to establish a program to increase the development of new drugs to treat pediatric cancers, and for other purposes. |
28 |
Bipartisan |
Referred to the Subcommittee on Health. |
| Feb. 2, 2017 |
H.R.820 |
To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes. |
371 |
Bipartisan |
Referred to the Subcommittee on Health. |
| July 29, 2015 |
H.R.3381 |
To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes. |
270 |
Bipartisan |
Received in the Senate. |
| July 14, 2016 |
H.R.5858 |
To amend the Federal Food, Drug, and Cosmetic Act to establish a program to provide additional incentives for the development of new drugs to treat pediatric cancers, and for other purposes. |
4 |
Bipartisan |
Referred to the House Committee on Energy and Commerce. |
| Feb. 12, 2015 |
H.R.909 |
To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes. |
10 |
Bipartisan |
Referred to the Subcommittee on Health. |
| Dec. 8, 2014 |
H.R.5805 |
To amend the Federal Food, Drug, and Cosmetic Act with respect to expanding access for breakthrough drugs, and for other purposes. |
0 |
|
Referred to the Subcommittee on Health. |
| Sept. 23, 2011 |
H.R.3059 |
To amend the Federal Food, Drug, and Cosmetic Act to improve the priority review voucher incentive program relating to tropical and rare pediatric diseases. |
173 |
Bipartisan |
Referred to the Subcommittee on Health. |
Searching...